News
- Author:
- Carolyn Crist
Publish date: September 30, 2022
Refractory celiac disease can be challenging to diagnose and treat.
News
- Author:
- Carolyn Crist
Publish date: September 28, 2022
“It’s a contentious issue, but it makes so much sense that, if what’s killing people is highly toxic drugs, we need to find a way to provide an opt...
News
- Author:
- Carolyn Crist
Publish date: September 22, 2022
“Boiling a medication can make it much more concentrated and change its properties in other ways.”
News
- Author:
- Carolyn Crist
Publish date: September 20, 2022
“It’s significant. It’s staggering. It’s heartbreaking.”
News
- Author:
- Carolyn Crist
Publish date: September 20, 2022
The American Academy of Pediatrics in a 2017 report concluded that "high-quality evidence" is lacking for spinal manipulation in children.
News
- Author:
- Carolyn Crist
Publish date: September 9, 2022
The risk of upper gastrointestinal bleeding was higher in men taking warfarin.
News
- Author:
- Carolyn Crist
Publish date: September 8, 2022
Controversy remains regarding the benefit of endoscopic retrograde cholangiopancreatography in the management of unexplained recurrent acute pancre...
News
- Author:
- Carolyn Crist
Publish date: September 1, 2022
“Even small declines in life expectancy of a tenth or two-tenths of a year mean that on a population level, a lot more people are dying prematurely...
News
- Author:
- Carolyn Crist
Publish date: September 1, 2022
The benefit was significant even at Model for End-Stage Liver Disease–Sodium scores as low as 11.
News
- Author:
- Carolyn Crist
Publish date: August 31, 2022
Abbott estimated that it will take about 6 weeks for Similac products to ship to stores. Production has restarted, which will be followed by “enhan...
News
- Author:
- Carolyn Crist
Publish date: August 29, 2022
“Treatment with Paxlovid significantly reduces the risk of hospitalization and death from COVID-19.”
News
- Author:
- Carolyn Crist
Publish date: August 26, 2022
Patients with GI symptoms were more likely to have higher Charlson Comorbidity Index scores and be 50 years and older.
News
- Author:
- Carolyn Crist
Publish date: August 24, 2022
The new shots target both the original spike protein on the coronavirus and the spike mutations carried by BA.4 and BA.5.
News
- Author:
- Carolyn Crist
Publish date: August 19, 2022
Although an effect may be expected, the researchers were surprised by the limited data regarding physical health.
News
- Author:
- Carolyn Crist
Publish date: August 18, 2022
About 9% of patients switched back to IV vedolizumab because of adverse events or fear of needles.
